Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1211 of 6351
-
New short radiation regimen aims to cut side effects in breast cancer treatment
Disease control Recruiting nowThe purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that causes few or mild side effects in women with newly diagnosed breast cancer or DCIS w…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
New daily shot could ease rare hormone disorder
Disease control CompletedDuring the first four weeks of the trial, participants were randomly assigned to one of four groups: three groups received fixed doses of TransCon PTH and one group received placebo. TransCon PTH or placebo were administered as a subcutaneous injection using a pre-filled injectio…
Phase 2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Freeze and fight: new combo therapy targets melanoma
Disease control CompletedMelanoma is the deadliest form of skin cancer and its incidence has doubled every 20 years in France, where this cancer is responsible of more than 1600 deaths each year. Patients with early diagnosis have good prognosis and can be generally cured by surgery only. Advanced melan…
Phase 1/2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Hepatitis c donor livers safely transplanted into healthy recipients
Disease control CompletedThis is an open-label, pilot trial to test the safety and efficacy of transplantation of livers from Hepatitis C seropositive non-viremic (HCV Ab+/NAT-) and HCV seropositive viremic (HCV Ab+/NAT+) donors to HCV seronegative recipients on the liver transplant waitlist. Treatment a…
Phase 2 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hair loss drug shows promise in large global trial
Disease control CompletedThis is a global Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have alopecia areata. Eligible patients from the prior studies B7931005 (NCT02974868) and B7981015 (NCT…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Major study aims to settle debate on best bladder cancer treatment
Knowledge-focused OngoingBladder cancer is the most common urinary tract cancer and the 5th most common cancer in the US (1). Yet bladder cancer research is underfunded relative to other common cancers. As a result, bladder cancer care is prone to evidence gaps that produce decision uncertainty for both …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Cash for care: nigeria study tests whether money can save mothers and babies
Prevention CompletedIt has been estimated that increasing the use of skilled care during childbirth could prevent up to 1.5 million maternal and newborn deaths and stillbirths by 2025. Conditional cash transfer programs, in which women receive cash payments conditioned on the use of maternal health …
Sponsor: RAND • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Can a spinal injection safely slow spinal muscular atrophy? a real-world study in korea seeks answers.
Disease control OngoingThe primary objective is to evaluate the safety of nusinersen sodium injection in the postmarketing setting in Korea. The secondary objective is to evaluate the effectiveness of nusinersen sodium injection in the postmarketing setting in Korea.
Sponsor: Biogen • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Promising new rabies vaccine passes phase 3 test
Prevention CompletedPrimary Objective: To demonstrate that Purified Vero Rabies Vaccine - Serum Free Vaccine generation 2 (VRVg-2) was non-inferior to Verorab and Imovax Rabies vaccines when co-administered with human rabies immunoglobulin (HRIG), in terms of proportion of participants achieving a …
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 17:51 UTC
-
Vitamin c boosts radiation for sarcoma? early trial shows promise
Disease control CompletedThis is a single-arm open-label phase Ib/II clinical study assessing the efficacy of concurrent high dose ascorbate in combination with radiotherapy in patients with locally advanced, resectable, high grade sarcomas.
Phase 1/2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Shining a light on brain aging: could NIR boost memory?
Knowledge-focused CompletedThe current study will test whether age-related cognitive and mood changes in older adults and those will be affected by near infrared (NIR) stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brai…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New stent aims to keep leg arteries open longer
Disease control CompletedThe purpose of this study (superiority trial) is to compare the Supera® Peripheral Stent System with a standard nitinol self-expanding stent for treatment of femoro-popliteal arterial occlusive disease. Hypothesis: The Supera® stent is superior to a standard nitinol self-expand…
Sponsor: Kantonsspital Winterthur KSW • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New malaria drug combo shows promise in kids
Disease control OngoingSingle-center phase II/III clinical investigation of the pharmacokinetics and pharmacodynamics of artemether-lumefantrine and dihydroartemisinin-piperaquine for gametocyte clearance and post-treatment chemoprotection in Zambian children with uncomplicated falciparum malaria.
Phase 2/3 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could hepatitis C-Positive kidneys be safe for transplant?
Disease control OngoingThis is an open-label, pilot trial to test the safety and efficacy of transplantation of kidneys from hepatitis C seropositive non-viremic (HCV Ab+/NAT-) and HCV seropositive viremic (HCV Ab+/NAT+) donors to HCV seronegative recipients on the kidney transplant waitlist. Treatment…
Phase 2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Diabetes drug metformin tested for fragile x symptoms
Symptom relief CompletedThis study is a controlled trial of metformin in individuals with fragile X syndrome between the ages of 6 and 35 years. Participants will be randomized in a double-blind design to either drug or placebo and will attend three visits to the study site in a 4-month period for a ser…
Phase 2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Shorter radiation may be as safe for High-Risk prostate cancer
Disease control OngoingThis is a phase 2 randomized study for High risk localized prostate cancer (T3 to T4 disease and/or PSA \> 20 and/or Gleason score ≥ 8) without evidence of distant and nodal metastasis. Patient will be randomized to:Arm 1 * Conventional IMRT RapidArc IMRT to prostate and pelvic…
Phase 2 • Sponsor: CCTU • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Needle instead of scalpel: new sperm retrieval method tested
Disease control OngoingThe objective of this study is to use ultrasound-guided rete testis flushing and aspiration technique to retrieve sperm, non-surgically, from the testes of azoospermic men. If sperm are retrieved by this method, it will provide a direct benefit to the infertile men. This protocol…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Immunotherapy-Ablation combo shows promise in early liver cancer trial
Disease control CompletedThis is a multicenter, single arm, prospective, open-label phase II trial investigating the clinical activity of peri-interventional treatment with the anti-PD1 antibody pembrolizumab in HCC patients who are candidates for local ablation via either radiofrequency ablation (RFA) o…
Phase 2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immunotherapy tackles precancerous mouth spots
Disease control Recruiting nowThis phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Epigenetic drugs aim to stop cancer return after transplant in kids
Disease control OngoingThe objective of this study is to evaluate the maximum tolerated (MTD) of vorinostat used in combination with low-dose azacitidine after allogeneic hematopoietic cell transplantation (alloHCT) for prevention of relapse of childhood myeloid malignancies.
Phase 1 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC